Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The clinical significance of p90-kDa ribosomal S6 kinase (RSK) family members in lung adenocarcinoma (LUAD) is unknown. The aim of this study was to analyze genomic alterations in RSK family membersand investigate the expression and clinicopathological significance of RSK4 in LUAD tissues. Genomic calterations of RSK family, overall survival, andinteraction networks were analyzed in patients with LUAD (n=522), using data from The Cancer Genome Atlas (TCGA) database. The expression of RSK4 protein was investigated in an independent cohort of patients with LUAD (n=127) by immunohistochemistry, and relationships between RSK4 protein levels and clinicopathological parameters of LUAD were analyzed. Patients with LUAD with RSK genomic alterations had significantly better overall survival than patients without alterations (P=0.026). mRNA was overexpressed in LUAD compared with noncancerous lung tissue (P=0.013), and the diagnostic value of expression was moderate, as evaluated by a value of 0.603 for the area under the receiver operator characteristic curve (95% CI, 0.551-0.655; P=0.01). RSK4 protein levels were significantly higher in LUAD than in para-carcinoma tissue (P=0.002); moreover, RSK4 protein expression was closely associated with TNM stage (P<0.001), tumor diameter (P<0.001), lymphatic metastasis (P<0.001), and distant metastasis (P=0.003). In conclusion, alterations to RSK family members may affect tumor progression in LUAD. RSK4 is a potentially useful molecular biomarker for LAUD diagnosis and may predict disease progression in patients with this condition.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966026 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Loss of Drosophila ribosomal protein S6 kinase II causes mitochondrial dysfunction and cell death.
Dis Model Mech
August 2025
MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.
Mitochondria are dynamic organelles that are critical for energy production in high-demand tissues, such as the brain and muscle, with fusion and fission maintaining network integrity. The dysregulation of these processes underlies pathologies, such as neurodegenerative diseases. Ribosomal S6 kinases (RSK1-4) are effectors of extracellular signal-regulated kinases (ERKs), with roles in cell survival and metabolism.
View Article and Find Full Text PDFRSK4 promotes the metastasis of clear cell renal cell carcinoma by activating RUNX1-mediated angiogenesis.
Cancer Biol Ther
December 2025
State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Air Force Military Medical University, Xi'an, China.
Ribosomal S6 protein kinase 4 (RSK4), a member of the serine‒threonine kinase family, plays a vital role in the Ras‒MAPK pathway. This kinase is responsible for managing several cellular activities, including cell growth, proliferation, survival, and mobility. In this study, we observed higher RSK4 protein expression in clear cell renal cell carcinoma (ccRCC) than in normal kidney tissue, and the overexpression of RSK4 might predict poor outcomes for ccRCC patients.
View Article and Find Full Text PDFBoolean Modeling of Biological Network Applied to Protein-Protein Interaction Network of Autism Patients.
Biology (Basel)
August 2024
School of Systems Biology, George Mason University, Fairfax, VA 22030, USA.
Cellular molecules interact with one another in a structured manner, defining a regulatory network topology that describes cellular mechanisms. Genetic mutations alter these networks' pathways, generating complex disorders such as autism spectrum disorder (ASD). Boolean models have assisted in understanding biological system dynamics since Kauffman's 1969 discovery, and various analytical tools for regulatory networks have been developed.
View Article and Find Full Text PDFExpression of RSK4 protein in non-small cell lung cancer tissues, adjacent tissues and its correlation with clinicopathological features.
Am J Transl Res
July 2024
Department of Burns and Wound Care Centre, The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou 310000, Zhejiang, China.
Objective: To evaluate the expression of Ribosomal S6 kinase 4 (RSK4) protein in non-small cell lung cancer (NSCLC) tissues and adjacent non-tumor tissues, and to elucidate its correlation with clinicopathological features of NSCLC.
Methods: We analyzed 100 NSCLC patients treated at the Second Affiliated Hospital of Zhejiang University School of Medicine from June 2020 to June 2022. Patient demographics and clinical data, including gender, age, history of diabetes, tumor location, degree of tumor differentiation, lymph node metastasis, and clinical stage, were collected.
Validation of positional candidates Rps6ka6 and Pou3f4 for a locus associated with skeletal muscle mass variability.
G3 (Bethesda)
May 2024
School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Article Synopsis
- Genetic variability plays a crucial role in differences in skeletal muscle mass, but the specific genes responsible are not well understood; this study focuses on Rps6ka6 and Pou3f4 genes located on chromosome X in mice.
- The study involved analyzing muscle samples from male CFW mice with different alleles linked to muscle mass, revealing that the "increasing" allele led to larger muscle size and more muscle fibers, particularly in the fast-twitch extensor digitorum longus muscle.
- Findings suggest that Rps6ka6 influences muscle fiber count in fast-twitch muscles, whereas the Pou3f4 gene impacts fiber numbers in slow-twitch muscles, indicating distinct genetic roles in muscle development.